$Recursion Pharmaceuticals, In

33
2
Favorite

著名垃圾級基金經理
2025-06-03

$Recursion Pharmaceuticals, Inc.(RXRX)$ 我选择买入RXRX，主要基于三点：一是生物医药行业前景广阔，老龄化加剧使创新药需求旺盛；二是公司研发实力强劲，核心在研药物进入关键临床阶段，针对特定病症疗效优异，上市后有望大幅提升营收；三是当前股价低估，市盈率低于行业均值，具备较大价值增长空间，因此具备较高投资价值。

RXRX

06-03 22:59

USRecursion Pharmaceuticals, Inc.

Side	Price \| Filled	Realized P&L
Buy Open	4.41 200	-- Closed

Recursion Pharmaceuticals, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（2）

Top
Latest

DeltaDrift
·2025-06-04
研发潜力如何？
Reply
Like
Report
著名垃圾級基金經理
·2025-06-06
這篇文章不錯，轉發給大家看看
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":442122461905432,"tweetId":"442122461905432","gmtCreate":1748962821997,"gmtModify":1788029220596,"author":{"id":4185857171023232,"idStr":"4185857171023232","authorId":4185857171023232,"authorIdStr":"4185857171023232","name":"著名垃圾級基金經理","avatar":"https://community-static.tradeup.com/news/d30f400de566c36d00e6b5d5280c5178","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.09.03","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"wearingBadges":[],"fanSize":399,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>我选择买入RXRX，主要基于三点：一是生物医药行业前景广阔，老龄化加剧使创新药需求旺盛；二是公司研发实力强劲，核心在研药物进入关键临床阶段，针对特定病症疗效优异，上市后有望大幅提升营收；三是当前股价低估，市盈率低于行业均值，具备较大价值增长空间，因此具备较高投资价值。</body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>我选择买入RXRX，主要基于三点：一是生物医药行业前景广阔，老龄化加剧使创新药需求旺盛；二是公司研发实力强劲，核心在研药物进入关键临床阶段，针对特定病症疗效优异，上市后有望大幅提升营收；三是当前股价低估，市盈率低于行业均值，具备较大价值增长空间，因此具备较高投资价值。</body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ 我选择买入RXRX，主要基于三点：一是生物医药行业前景广阔，老龄化加剧使创新药需求旺盛；二是公司研发实力强劲，核心在研药物进入关键临床阶段，针对特定病症疗效优异，上市后有望大幅提升营收；三是当前股价低估，市盈率低于行业均值，具备较大价值增长空间，因此具备较高投资价值。","highlighted":1,"essential":1,"paper":1,"likeSize":33,"commentSize":2,"repostSize":2,"favoriteSize":0,"link":"https://ttm.financial/post/442122461905432","repostId":0,"isVote":1,"tweetType":1,"viewCount":725,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4185857171023232","orderId":"39329924033301504","kind":"TRADE","symbol":"RXRX","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/RXRX","symbolName":"Recursion Pharmaceuticals, Inc.","market":"US","action":"BUY","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Recursion Pharmaceuticals, Inc.","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":4.41,"createTime":1748962785,"filledQuantity":"200","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Recursion Pharmaceuticals, Inc.","contractExtraDescription":"RXRX","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":-0.209},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","USER_PROVIDED_TEXT"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":252,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":442370173522096,"commentId":"442370173522096","gmtCreate":1749027323906,"gmtModify":1749027328986,"authorId":10000000000011028,"author":{"id":10000000000011028,"idStr":"10000000000011028","authorId":10000000000011028,"name":"DeltaDrift","avatar":"https://community-static.tradeup.com/news/11d675a610354289230d3a2f6c6e4c88","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":442122461905432,"objectIdStr":"442122461905432","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"研发潜力如何？","text":"研发潜力如何？","html":"研发潜力如何？","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":443198585389728,"commentId":"443198585389728","gmtCreate":1749224986592,"gmtModify":1749224990200,"authorId":4185857171023232,"author":{"id":4185857171023232,"idStr":"4185857171023232","authorId":4185857171023232,"name":"著名垃圾級基金經理","avatar":"https://community-static.tradeup.com/news/d30f400de566c36d00e6b5d5280c5178","vip":1,"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLinkType":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","redirectLinkValidityFrom":1679961600000,"redirectLinkValidityTo":1996963200000,"hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.09.03","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1,"categoryType":2007,"isScarce":0,"effectEnabled":0,"wearingSort":0,"validityTo":"2026.10.03","validityToTimestamp":1791001202309}],"wearingBadges":[]},"repliedAuthorId":0,"objectId":442122461905432,"objectIdStr":"442122461905432","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"這篇文章不錯，轉發給大家看看","text":"這篇文章不錯，轉發給大家看看","html":"這篇文章不錯，轉發給大家看看","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}